Autopsy report · NCT02375334

Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

“Support Staff Left Institution”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 11 months before it stopped.
• 18 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Malignant Glioma; Myelosuppression

Interventions

Medical Chart Review

Participants

18

Sites

1

Countries

United States

Trials that died the same way

• Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients
  “Pl left institution” (65% match in meaning)
• Virtual Reality in Wide-Awake Hand Surgery
  “Researchers left institution” (62% match in meaning)
• Efficacy of Amniotic Membranes in Complex Genitourinary Reconstruction
  “Lack of supporting staff” (62% match in meaning)
• Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel)
  “Study team left institution; no one remaining to finish study” (61% match in meaning)
• Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
  “Collaborators left the institution.” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.